US FDA revises Lilly's COVID-19 antibody combo EUA for use after exposure to virus
#1

Sept 16 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has revised its emergency use authorization for Eli Lilly's (LLY.N) COVID-19 antibody cocktail to include for use in patients who have been exposed to the virus and are at high risk for progression to severe disease.


https://www.reuters.com/world/us/fda-rev...021-09-16/
Reply
#2

The price for a dose of 1,200 mg (600 mg of Casirivimab and 600 mg of Imdevimab) is Rs 59,750. A multi-dose pack (each pack can treat two patients) has been priced at Rs 1,19,500. It has to be stored at 2-8 degrees Celsius.

https://www.indiatoday.in/coronavirus-ou...2021-05-27
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)